Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166595
Status:
COMPLETED
Last Update Posted:
2014-01-28
First Post:
2005-09-09
Brief Title:
Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder PDD
Sponsor:
Childrens Hospital Medical Center Cincinnati
Organization:
Childrens Hospital Medical Center Cincinnati
Study Overview
Official Title:
Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder PDD
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if the known differences in genes influence drug metabolizing enzymes and receptors that are involved in risperidone drug action The study will determine if differences in these genes will change the concentration of risperidone in the blood over time in children in relation to side effects and clinical response to risperidone
Detailed Description:
To the knowledge of the investigators there are no studies documenting the pharmacokinetics and pharmacogenetics of risperidone in children with PDD Currently the PPRU network is conducting a PK study whose aim is to establish a new enantio-selective micro-assay methodology and to generate preliminary population PK data of risperidone and its metabolites in PDD This study focuses on pharmacogenetic evaluation of PDD patients having little or no effect those that are unusually sensitive and those experiencing drug toxicityadverse events at standard risperidone dosages
In this study two 5 ml blood samples will be drawn at a regulary scheduled PK visit Alternatively pooled waste blood samples or a buccal swab can be obtained
In this study two 5 ml blood samples will be drawn at a regulary scheduled PK visit Alternatively pooled waste blood samples or a buccal swab can be obtained
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None